(0516 to 0522) respectively; this difference was significant. The relative risk of having a boy for women who required manual removal of the placenta was 0 882 (0 85 to 0 92); thus the proportion of boys born in this group was indeed significantly lower than that in the reference population. Logistic regression showed no significant trend in the proportion of girls born with increasing gravidity in either the reference group (p>0 5; x2=0 00, df=1) or the group who required manual removal of the placenta (p>0 5; x2=004, df= 1).
Comment
Undue emphasis has been placed on the study of histologically proved cases of placenta accreta, whereas this condition is a clinical entity.3 As manual removal of the placenta is thought to indicate a degree of placenta accreta its use as a surrogate for placenta accreta is justified.
Successful pregnancy is thought to depend on immunological stimuli provided by antigenic disparity between the fetus and the mother. Inhaled corticosteroids have proved efficacious in treating bronchial asthma, and severe systemic side effects seem to be rare, even with high dosages.' Because of this combination of efficacy and tolerability the indications for their use are widening and higher dosages are being prescribed.
Despite the lack of adrenal suppression in patients on high dose (1 5-2 0 mg/day) inhalation corticosteroids' skin thinning and purpura were found to occur more often in such patients. A severe complication of long term treatment with oral corticosteroids is osteoporosis, which is mainly caused by depression of bone formation. Serum osteocalcin, which is produced by the osteoblasts, -seems to be a protein produced exclusively by bone forming cells,' and it has been shown that the use of oral corticosteroids results in lowered concentrations of serum osteocalcin.4
We aimed to determine the effect of beclomethasone inhalation on osteocalcin concentrations in healthy volunteers. Subjects, methods, and results Eight healthy volunteers (three premenopausal women and five men; mean (SD) age 32 6 (8 2) years, range 26-51) were studied; they were not taking any drugs. After supervised training with a placebo device, all subjects used beclomethasone inhalation for two weeks in four doses of 500 Ftg a day. They were studied before start of treatment (day 1), after one and two weeks of treatment (days 8 and 15), and one and two weeks after stopping (days 22 and 29) . Because it has been reported that osteocalcin has a diurnal variation,5 blood was drawn hourly from 0900 until 1500 through an indwelling catheter. During treatment (days 8 and 15) beclomethasone was given just after a blood sample had been drawn at 0900 and 1400 hours.
Osteocalcin concentrations were determined by a commercial radioimmunoassay (IncStar, Stillwater, Minnesota); interassay and intra-assay variations were 5 4% and 6-1% respectively. A multivariate analysis for repeated measurements was used to analyse the data, and the within subject covariance matrix was assumed to be of the compound type. The likelihood ratio test was used to test for a treatment effect and for a time effect (for example, diurnal variation) and to find a model consistent with the observed data (figure). 
